D H Au

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Risk of myocardial ischaemia and beta-adrenoceptor agonists
    D H Au
    Department of Veterans Affairs, VA Puget Sound Health Care System, Seattle, WA 98108, USA
    Ann Med 33:287-90. 2001
  2. pmc The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease
    Colin R Cooke
    Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA
    BMC Health Serv Res 11:37. 2011
  3. pmc Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort
    Christopher G Slatore
    Portland VA Medical Center, Health Services Research and Development, Portland, OR, USA
    BMC Cancer 11:228. 2011
  4. pmc The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, 1660 S Columbian Way 152, Seattle, WA 98108, USA
    J Gen Intern Med 24:457-63. 2009
  5. ncbi request reprint Regional variations in health status
    D H Au
    Northwest Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, Washington, USA
    Med Care 39:879-88. 2001
  6. ncbi request reprint Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, Washington 98108, USA
    COPD 2:209-16. 2005
  7. ncbi request reprint Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, Seattle, Wash, USA
    Arch Intern Med 166:326-31. 2006
  8. ncbi request reprint Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease
    David H Au
    Health Services Research and Development Northwest Center of Excellence, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Am J Med 117:925-31. 2004
  9. ncbi request reprint Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists
    David H Au
    Health Services Research and Development, Division of Pulmonary and Critical Care Medicine, VA Puget Sound Health Care System, Seattle, Wash 98108, USA
    Am Heart J 148:915-20. 2004
  10. ncbi request reprint Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction
    David H Au
    Health Services Research and Development, Northwest Center of Excellence, VA Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108, USA
    Chest 123:1964-9. 2003

Detail Information

Publications34

  1. ncbi request reprint Risk of myocardial ischaemia and beta-adrenoceptor agonists
    D H Au
    Department of Veterans Affairs, VA Puget Sound Health Care System, Seattle, WA 98108, USA
    Ann Med 33:287-90. 2001
    ..Furthermore, careful consideration should be given to distinguish symptoms caused by cardiovascular versus respiratory aetiologies...
  2. pmc The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease
    Colin R Cooke
    Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA
    BMC Health Serv Res 11:37. 2011
    ..We sought to develop a predictive model utilizing administrative data to accurately identify patients with COPD...
  3. pmc Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort
    Christopher G Slatore
    Portland VA Medical Center, Health Services Research and Development, Portland, OR, USA
    BMC Cancer 11:228. 2011
    ..We used data from a prospective cohort study to evaluate associations of demographic, health history, and health behaviors with early versus late stage at diagnosis of non-small cell lung cancer (NSCLC)...
  4. pmc The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, 1660 S Columbian Way 152, Seattle, WA 98108, USA
    J Gen Intern Med 24:457-63. 2009
    ..There is a paucity of evidence about the effects of smoking cessation on the risk of COPD exacerbations...
  5. ncbi request reprint Regional variations in health status
    D H Au
    Northwest Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, Washington, USA
    Med Care 39:879-88. 2001
    ..Knowledge about variations in the health status of patients seeking primary care in different parts of the United States is limited...
  6. ncbi request reprint Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, Washington 98108, USA
    COPD 2:209-16. 2005
    ..67) and SOBQ (r = 0.50). The Chronic Bronchitis Symptoms Assessment Scale is an easy to administer, once daily or once weekly, valid and reliable outcome measure for assessing symptom severity among patients with chronic bronchitis...
  7. ncbi request reprint Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer
    David H Au
    Health Services Research and Development, VA Puget Sound Health Care System, Seattle, Wash, USA
    Arch Intern Med 166:326-31. 2006
    ....
  8. ncbi request reprint Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease
    David H Au
    Health Services Research and Development Northwest Center of Excellence, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Am J Med 117:925-31. 2004
    ..To assess the association between the type of antihypertensive medication and all-cause mortality among patients with chronic obstructive pulmonary disease (COPD)...
  9. ncbi request reprint Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists
    David H Au
    Health Services Research and Development, Division of Pulmonary and Critical Care Medicine, VA Puget Sound Health Care System, Seattle, Wash 98108, USA
    Am Heart J 148:915-20. 2004
    ..Recent reports suggest an association between beta-agonists and the risk of incident chronic heart failure (CHF). We sought to examine the association between inhaled beta-agonists and risk of incident and nonincident heart failure...
  10. ncbi request reprint Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction
    David H Au
    Health Services Research and Development, Northwest Center of Excellence, VA Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108, USA
    Chest 123:1964-9. 2003
    ..We sought to determine if use of selective beta(2)-agonists was associated with hospitalization for heart failure and all-cause mortality...
  11. ncbi request reprint Comparing methods to identify general internal medicine clinic patients with chronic heart failure
    E M Udris
    Northwest Health Services Research and Development Center of Excellence, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA
    Am Heart J 142:1003-9. 2001
    ..The purpose of this study was to develop and validate a computerized tool using clinical information that is commonly available to identify patients with left ventricular systolic dysfunction (LVSD)...
  12. pmc Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease
    Tanyalak Parimon
    Department of Medicine, University of Washington, Seattle, Washington, USA
    Am J Respir Crit Care Med 175:712-9. 2007
    ..Lung cancer is a frequent cause of death among patients with chronic obstructive pulmonary disease (COPD). We examined whether the use of inhaled corticosteroids among patients with COPD was associated with a decreased risk of lung cancer...
  13. doi request reprint The association between alcohol consumption and risk of COPD exacerbation in a veteran population
    Courtney C Greene
    Department of Medicine, University of Washington, Campus Box 356522, 1959 NE Pacific St, Seattle, WA 98195, USA
    Chest 134:761-7. 2008
    ..Our objective was to evaluate the association between alcohol consumption and the subsequent risk of COPD exacerbation...
  14. ncbi request reprint Alcohol screening scores and medication nonadherence
    Chris L Bryson
    Health Services Research and Development Northwest Center of Excellence, Veterans Affairs Puget Sound Health Care System, and University of Washington, Seattle, Washington 98101, USA
    Ann Intern Med 149:795-804. 2008
    ..Medication nonadherence is common and is associated with adverse outcomes. Alcohol misuse may be a risk factor for nonadherence; however, evidence is limited...
  15. ncbi request reprint Cardiovascular risk factor control among veterans with diabetes: the ambulatory care quality improvement project
    Nicholas L Smith
    Seattle Epidemiologic Research and Information Center, VA Puget Sound Health Care System, Seattle, Washington, USA
    Diabetes Care 27:B33-8. 2004
    ..To describe the extent to which hyperglycemia, hypertension, and dyslipidemia are currently detected, treated, and controlled in U.S. veterans with diabetes with and without ischemic heart disease (IHD)...
  16. doi request reprint Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer
    Christopher G Slatore
    Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA
    J Thorac Oncol 4:499-504. 2009
    ..Perioperative smoking cessation is associated with improved survival, but the cost-effectiveness of a smoking cessation program initiated immediately before surgery is unknown...
  17. pmc Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study
    Christopher G Slatore
    Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 98195 6522, USA
    Cancer Epidemiol Biomarkers Prev 18:1203-7. 2009
    ..Lung cancer is the most common cause of cancer-related mortality. Smoking cessation is crucial to decrease risk, but additional prevention modalities are needed. The use of nonsteroidal anti-inflammatory drugs (NSAID) may be promising...
  18. doi request reprint The association of inhaled corticosteroid use with serum glucose concentration in a large cohort
    Christopher G Slatore
    Health Services Research and Development, VA Puget Sound Health Care System, Seattle, Wash 98101, USA
    Am J Med 122:472-8. 2009
    ..Inhaled corticosteroids (ICSs) are widely used in the treatment of obstructive lung disease. ICSs have been shown to be systemically absorbed. The association between ICS and serum glucose concentration is unknown...
  19. doi request reprint The association of depression and preferences for life-sustaining treatments in veterans with chronic obstructive pulmonary disease
    Lynn F Reinke
    Health Services Research and Development, Seattle, Washington, USA
    J Pain Symptom Manage 41:402-11. 2011
    ..Examining the relationship between patient preferences for life-sustaining treatments and depressive symptoms is important for clinicians engaging in end-of-life care discussions...
  20. ncbi request reprint A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp)
    Chris L Bryson
    Health Services Research and Development Northwest Center of Excellence, Seattle, Washington 98101, USA
    Med Care 45:497-504. 2007
    ..There are many measures of refill adherence available, but few have been designed or validated for use with repeated measures designs and short observation periods...
  21. ncbi request reprint Drifting in a shrinking future: living with advanced heart failure
    Cynthia M Dougherty
    Biobehavioral Nursing and Health Systems, University of Washington School of Nursing, Seattle, WA 98195, USA
    J Cardiovasc Nurs 22:480-7. 2007
    ..Patients with advanced heart failure (HF) have an uncertain prognosis and low rates of advance care planning and hospice use. The purpose of this study was to describe how patients view and plan for their future...
  22. ncbi request reprint Communication about palliative care for patients with chronic obstructive pulmonary disease
    J Randall Curtis
    Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
    J Palliat Care 21:157-64. 2005
    ..Further research is needed to develop and test interventions that can enhance patient-physician communication about palliative and EOL care for patients with COPD, and we describe our perspective on a research agenda in each area...
  23. pmc Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer
    Christopher G Slatore
    University of Washington, Division of Pulmonary and Critical Care Medicine, 1959 NE Pacific Street, Box 356522, Seattle, WA 98195 6522, USA
    Am J Respir Crit Care Med 177:524-30. 2008
    ..Lung cancer is the leading cause of cancer-related mortality in the United States. Although supplements are used by half the population, limited information is available about their specific effect on lung cancer risk...
  24. ncbi request reprint Intraindividual change in SF-36 in ambulatory clinic primary care patients predicted mortality and hospitalizations
    Vincent S Fan
    Health Services Research and Development 152, Center of Excellence, VA Puget Sound Health Care System, 1600 South Columbian Way, Seattle, WA 98108 1597, USA
    J Clin Epidemiol 57:277-83. 2004
    ..We sought to determine whether change in SF-36 scores over time is associated with the risk of adverse outcomes...
  25. ncbi request reprint Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis
    Vincent S Fan
    Department of Medicine, University of Washington, Seattle, WA 98108
    Am J Respir Crit Care Med 168:1488-94. 2003
    ..64-1.13) or COPD exacerbations (HR, 1.13; 95% CI, 0.94-1.36). In a time-dependent study of outpatients with COPD, adherence to inhaled corticosteroid use was not associated with a decreased risk of mortality or exacerbations...
  26. ncbi request reprint Effects of sustained audit/feedback on self-reported health status of primary care patients
    Stephan D Fihn
    Northwest VA Health Services Research and Development Center of Excellence, Seattle, Washington 98108, USA
    Am J Med 116:241-8. 2004
    ..Because limited audit/feedback of health status information has yielded mixed results, we evaluated the effects of a sustained program of audit/feedback on patient health and satisfaction...
  27. ncbi request reprint Patient-physician communication about end-of-life care for patients with severe COPD
    J R Curtis
    Division of Pulmonary and Critical Care Medicine, Dept of Medicine, School of Medicine, Seattle, WA 98104, USA
    Eur Respir J 24:200-5. 2004
    ..Future studies should determine the responsiveness of these items to interventions, and the effect such interventions have on patient satisfaction and quality of care...
  28. pmc Patient-clinician communication: associations with important health outcomes among veterans with COPD
    Christopher G Slatore
    Health Services Research and Development, Portland Veterans Affairs Medical Center, Portland, OR 97239, USA
    Chest 138:628-34. 2010
    ..High quality patient-clinician communication is widely advocated, but little is known about which health outcomes are associated with communication for patients with COPD...
  29. doi request reprint Cardiovascular events associated with ipratropium bromide in COPD
    Sarika S Ogale
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
    Chest 137:13-9. 2010
    ..We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs)...
  30. ncbi request reprint Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers
    Jason W Chien
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    COPD 4:339-46. 2007
    ..These data indicate an FEV(1)/FVC<0.7 among smokers is significantly associated with faster airflow loss, and an increased risk for developing lung cancer, even among those individuals with a normal FEV(1)...
  31. ncbi request reprint Alcohol screening scores and risk of hospitalizations for GI conditions in men
    David H Au
    Health Services Research and Development, Seattle, Washington, USA
    Alcohol Clin Exp Res 31:443-51. 2007
    ....
  32. ncbi request reprint Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction
    David H Au
    Department of Medicine, University of Washington, Seattle 98108, USA
    Chest 121:846-51. 2002
    ..We further examined the association between acute coronary syndromes and inhaled beta-agonist therapy...
  33. ncbi request reprint Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease
    Todd A Lee
    Hines Veterans Affairs Hospital, Hines, Illinois 60141, USA
    Ann Intern Med 149:380-90. 2008
    ..Concerns exist regarding increased risk for mortality associated with some chronic obstructive pulmonary disease (COPD) medications...
  34. doi request reprint Use of beta blockers in patients with COPD
    David H Au
    Thorax 63:296-8. 2008